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A 35yearold female presented with swelling anterior neck, painful deglutition, and cold intolerance for 4 years. Thyroid function tests revealed a hypothyroid profile, after which she was put on thyroid hormone replacement. Highresolution sonography showed diffusely enlarged right lobe of the thyroid gland (5.5 cm × 4.0 cm) with heterogeneous echotexture and multiple tiny hypoechoic nodules. Fineneedle aspiration (FNA) smears from the right lobe revealed clusters of follicular epithelial cells with abundant lymphocytic and plasma cell infiltration. Follicular destruction, Hürthle cell change, epithelioid histiocytes, and multinucleate giant cells were also seen, consistent with HT [ Figure 1 ]. Serum antimicrosomal antibody titer was high (203 IU/ml; normal < 34 IU/ml). Complete hemogram, blood sugar, lipid profile, and serum anti nuclear antibody were within normal limits.
The patient also complained of itching and irritation in the scalp, with the loss of hair and scaling since 1.5 years. The dermatological evaluation revealed an irregular 6 cm × 4 cm scarring alopecia on the right temporoparietal region [ Figure 2a ] and an oblong 5 cm × 2 cm similar area on the left temporal region. Follicular plugs, focal violaceous brown discoloration and residual tufts of hair were seen. Incision biopsy from the scalp lesion showed atrophied epidermis, follicular plugging, wedgeshaped hypergranulosis, elongated rete ridges, and basal vacuolar degeneration. The dermis showed a marked loss of pilosebaceous units with perifollicular fibrosis, resulting in dense fibrous tracts. Pigment incontinence, sparse perifollicular, and perivascular lymphocytic infiltrate were also seen [ Figure 2b ]. The histopathological features were consistent with LPP. The patient was put on oral and topical corticosteroids along with thyroid hormone supplement; followup visits showed gradual symptomatic improvement.
Lichen planopilaris usually occurs in the middleaged, with females being affected more than males. [6] In due course, it may progress to marked fibrosis, morphologically resembling Pseudopelade of Brocq. Both lichen planus (LP) and LPP are often associated with other immunological conditions such as thymoma, myasthenia gravis, dermatitis herpetiformis, vitiligo, hepatitis, Crohn's disease, and ulcerative colitis. [2] Alopecia in thyroid disorders is usually noncicatricial, such as diffuse alopecia, AA or androgenetic alopecia. [3, 4, 5, 7] Association of alopecia and thyroid dysfunction has been found in conditions such as chronic urticaria, vitiligo, acanthosis nigricans, psoriasis, and seborrheic dermatitis. [4, 5] Thyroid abnormalities in these situations include thyroiditis, cysts, nodules, and rarely papillary thyroid carcinoma. [7] Autoimmune diseases associated with HT include type I diabetes mellitus, systemic lupus erythematosus, and celiac disease. [8] The association of scarring alopecia due to LPP with thyroid disorders has been rarely described. [1, 2] A retrospective casecontrol study showing an association of LPP and thyroid diseases involving 166 cases has mentioned 10 cases of HT. [1] However, the study could have been more elaborative if it had provided some histological illustrations and mentioned the number of cases in which scalp biopsy, thyroid aspiration cytology, ultrasonography, thyroid function tests, and serum antimicrosomal antibody were available. In our recently established center, six other patients diagnosed with LPP during a span of one year did not show clinical or biochemical evidence of thyroid dysfunction.
Two recently published studies show an association of another lichenoid lesion, oral LP with thyroid disorders, including HT. [9, 10] A predisposing role of HT may be suggested in the context that circulating antithyroid antibodies may trigger an autoimmune response in the mucosa and skin, leading to the development of lichenoid lesions. [10] Treatment strategies for LPP are challenging; immunosuppressive and antiinflammatory agents are mainly targeted toward symptomatic relief, control of inflammation, and arrest of hair loss. Damage is permanent in areas of follicular destruction, and hair regrowth is usually not possible. [6] To conclude, although nonscarring alopecia like AA is known to be associated with thyroid disorders, co occurrence of scarring alopecia due to LPP and autoimmune thyroid disorders has been seldom described. We herein like to add to the current literature a rare case with thyroid enlargement, which revealed HT on FNA and serum assays, with associated progressive scarring alopecia due to LPP. This association highlights the importance of evaluating the thyroid profile in patients with cicatricial alopecia due to LPP.
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